ADXSD
Advaxis, Inc.

26,431
Mkt Cap
$25.73M
Volume
480,276.00
52W High
$0.801
52W Low
$0.0011
Price
$1.31
ADXSD Fundamentals
Prev Close
$0.5899
Open
$0.9249
50D MA
$0.21
Beta
-16.63
Avg. Volume
10,961.40
Loading...
Loading...

About

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Its lead candidates are the oral gamma secretase inhibitor, AL102, for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. The company was founded on June 5, 1987 and is headquartered in Monmouth Junction, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Advaxis, Inc.?
What is the 52-week high for Advaxis, Inc.?
What is the 52-week low for Advaxis, Inc.?
What is Advaxis, Inc. stock price today?
What was Advaxis, Inc. stock price yesterday?
What is the 50-day moving average of Advaxis, Inc.?

Latest ADXSD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.